L. Karen Smith

Affiliations

  • Director at Antares Pharma Inc. (ATRS), 2021-06-14
  • Evp, Chief Medical Officer at Emergent Biosolutions Inc. (EBS), 2021-05-11
  • Director at Acceleron Pharma Inc (XLRN), 2021-04-06
  • Director at Sangamo Therapeutics Inc (SGMO), 2021-03-02
  • Evp, R&d And Cmo at Jazz Pharmaceuticals Plc (JAZZ), 2018-03-07
  • Director at Sucampo Pharmaceuticals Inc. (SCMP), 2018-02-13
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
JAZZ $137.26 1 Officer 14,182 2016-08-12 Filing
JAZZ $137.10 607 Officer 14,181 2016-08-12 Filing
JAZZ $143.63 580 Officer 13,574 2016-07-13 Filing
JAZZ $149.61 557 Officer 12,994 2016-06-13 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
XLRN $141.15 641 Director 1,622 2021-04-05 Filing
XLRN $140.13 11,223 Director 2,263 2021-04-05 Filing
XLRN $137.92 941 Director 4,561 2021-04-01 Filing
XLRN $136.92 3,796 Director 5,502 2021-04-01 Filing
XLRN $136.22 2,987 Director 9,298 2021-04-01 Filing